The United States has dramatically increased behavioral health spending, reaching $329 billion in 2022—a 94% rise since 2012—while experiencing declining mental health outcomes, according to the Florida chapter of the Citizens Commission on Human Rights (CCHR).
The organization points to significant financial investment in mental health services, averaging $1,564 annually per person, which represents the highest healthcare expenditure globally. Despite this substantial spending, a Commonwealth Fund report reveals that the United States continues to experience lower life expectancy and higher suicide rates compared to peer nations.
CCHR Florida President Diane Stein criticizes the current mental health treatment landscape, suggesting an problematic alliance between psychiatric and pharmaceutical industries drives excessive spending without demonstrable improvements in patient wellbeing.
Of particular concern is the continued use of electroconvulsive therapy (ECT), which Stein describes as a controversial treatment potentially causing severe side effects. With patients receiving 5-15 treatments costing between $300 to $1,000 each, the financial and health implications are significant.
The organization argues that current mental health approaches require critical examination, emphasizing the need for alternative treatment methods and increased transparency in psychiatric care practices.
